Porcine cytochrome P450 3A: current status on expression and regulation

被引:0
|
作者
Martin Krøyer Rasmussen
机构
[1] Aarhus University,Department of Food Science
来源
Archives of Toxicology | 2020年 / 94卷
关键词
Pig; Swine; Diet; Food-drug interaction; Drug metabolism; Phase 1 metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
The cytochrome P450s (CYPs) constitute a family of enzymes maintaining vital functions in the body and are mostly recognized for their significant role in detoxification. Of the CYP subfamilies, CYP3A, is one of the most active in the clearance of drugs and other xenobiotics. During the last decades, much focus has been on exploring different models for human CYP3A regulation, expression and activity. In that respect, the growing knowledge of the porcine CYP3As is of great interest. Although many aspects of porcine CYP3A regulation and activity are still unknown, the current literature provides a basic understanding of the porcine CYP3As that can be used e.g., when translating results from studies done in the porcine model into human settings. In this review, the current knowledge about porcine CYP3A expression, regulation, activity and metabolic significance are highlighted. Future research needs are also identified.
引用
收藏
页码:1899 / 1914
页数:15
相关论文
共 50 条
  • [21] Porcine cytochrome P450 and metabolism
    Skaanild, Mette Tingleff
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (11) : 1421 - 1427
  • [22] Comparison of human and porcine cytochrome P450 expression.
    Liu, J
    Yano, N
    Rifai, A
    Naik, S
    Santangini, H
    Trenkler, D
    Jauregui, HO
    HEPATOLOGY, 1998, 28 (04) : 493A - 493A
  • [23] REGULATION OF HEPATIC CYTOCHROME P450 3A (CYP3A) ACTIVITY BY MICRORNAS (MIRNAS)
    Vuppalanchi, Raj
    Goswami, Chirayu P.
    Nalamasu, Rohit
    Muralidharan, Sriya
    Liang Tiebing
    Bell, Lauren N.
    Jones, David R.
    Li, Lang
    Chalasani, Naga P.
    HEPATOLOGY, 2011, 54 : 718A - 718A
  • [24] Regulation of cytochrome P450 gene expression and activity
    Maurel, P.
    Pascussi, J. M.
    Gerbal-Chaloin, S.
    Daujat, M.
    Vilarem, M. J.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 24 - 24
  • [25] Estrogen regulation of the expression of a cytochrome P450 isoenzyme
    Szeberenyi, J
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2004, 32 (06) : 412 - 414
  • [26] Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
    Yasuda, K
    Lan, LB
    Sanglard, D
    Furuya, K
    Schuetz, JD
    Schuetz, EG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01): : 323 - 332
  • [27] Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA
    Koch, I
    Weil, R
    Wolbold, R
    Brockmöller, J
    Hustert, E
    Burk, O
    Neussler, A
    Neuhaus, P
    Eichelbaum, M
    Zanger, U
    Wojnowski, L
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) : 1108 - 1114
  • [28] Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
    Roberts, Jessica K.
    Moore, Chad D.
    Ward, Robert M.
    Yost, Garold S.
    Reilly, Christopher A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (02): : 308 - 316
  • [29] Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes
    Hrycay, E. G.
    Bandiera, S. M.
    CURRENT DRUG METABOLISM, 2009, 10 (10) : 1151 - 1183
  • [30] Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update
    Anglicheau, Dany
    Legendre, Christophe
    Beaune, Philippe
    Thervet, Eric
    PHARMACOGENOMICS, 2007, 8 (07) : 835 - 849